Article
Effect of high-dose clopidogrel according to CYP2C19*2 genotype in patients undergoing percutaneous coronary intervention- a systematic review and meta-analysis.
Thrombosis research - 1 Mar 2015
Zhang Lanning, Yang Jie, Zhu Xiaoquan, Wang Xuyun, Peng Li, Li Xiaoqi, Cheng Peng, Yin Tong
Abstract excerpt
INTRODUCTION: High-dose clopidogrel has been recommended to overcome clopidogrel non-responsiveness in patients undergoing percutaneous coronary intervention (PCI), especially those with CYP2C19 loss-of-function genotypes. However, there is controversy over the pharmacodynamics and clinical effects of the strategy. This meta-analysis was conducted to evaluate the antiplatelet effects of high-dose clopidogrel...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
